Drug Profile

D tagatose - Biospherics.net

Alternative Names: BSN-175

Latest Information Update: 12 Oct 2022

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Yes - Prader-Willi syndrome
New Molecular Entity No

12 Oct 2022 D tagatose is still in phase III trials for Prader Willi syndrome in USA (Biospherics.net pipeline, October 2022)
26 Aug 2020 Phase-III clinical trials in Prader-Willi syndrome in USA (PO), before August 2020 (Biospherics.net pipeline, August 2020)
26 Aug 2020 Biospherics.net completes a phase II and a phase III trial for Prader-Willi syndrome, before August 2020 (Biospherics.net website, August 2020)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com